Editorial
Unraveling the genomic complexity of small-cell lung cancer
Translational Lung Cancer Research
2016;
5
(4)
:363-366
.
(29 August 2016)
B-RAF mutation in non-small cell lung cancer: the sleeping beauty is waking up
Translational Lung Cancer Research
2016;
5
(4)
:367-369
.
(29 August 2016)
Tumor lymphocytic infiltration in non-small cell lung cancer: the ultimate prognostic marker?
Translational Lung Cancer Research
2016;
5
(4)
:370-372
.
(29 August 2016)
Improved overall survival following tyrosine kinase inhibitor (TKI) treatment in NSCLC—are we making progress?
Translational Lung Cancer Research
2016;
5
(4)
:373-376
.
(29 August 2016)
Review Article
From diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules, a summary of the 2015 Chinese-German Lung Cancer Expert Panel
Translational Lung Cancer Research
2016;
5
(4)
:377-388
.
(29 August 2016)
Targeting angiogenesis in small cell lung cancer
Translational Lung Cancer Research
2016;
5
(4)
:389-400
.
(29 August 2016)
Histopathological transformation to small-cell lung carcinoma in non-small-cell lung carcinoma tumors
Translational Lung Cancer Research
2016;
5
(4)
:401-412
.
(29 August 2016)
Original Article
S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer
Translational Lung Cancer Research
2016;
5
(4)
:413-419
.
(29 August 2016)
Controversies on Lung Cancer: Pros and Cons (Section Chairs: Suresh Senan, Helmut H. Popper)1
Pros: Can tissue biopsy be replaced by liquid biopsy?
Translational Lung Cancer Research
2016;
5
(4)
:420-423
.
(29 August 2016)
Cons: Can liquid biopsy replace tissue biopsy?—the US experience
Translational Lung Cancer Research
2016;
5
(4)
:424-427
.
(29 August 2016)
Rebuttal from Dr. Hofman and Dr. Ilié
Translational Lung Cancer Research
2016;
5
(4)
:428-429
.
(29 August 2016)
Rebuttal from Dr. Mino-Kenudson
Translational Lung Cancer Research
2016;
5
(4)
:430-432
.
(29 August 2016)
Commentary on tumor heterogeneity
Translational Lung Cancer Research
2016;
5
(4)
:433-435
.
(29 August 2016)
Evidence-Based Medicine2
Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis
Translational Lung Cancer Research
2016;
5
(4)
:436-442
.
(29 August 2016)
Perspective
Integrative physicians and an herbal cancer “cure”
Translational Lung Cancer Research
2016;
5
(4)
:443-445
.
(29 August 2016)
Commentary
Afatinib in lung cancer harboring EGFR mutation in the LUX-Lung trials: six plus three is greater than seven?
Translational Lung Cancer Research
2016;
5
(4)
:446-449
.
(29 August 2016)
Correspondence
Genomic alterations in small cell lung cancer and their clinical relevance
Translational Lung Cancer Research
2016;
5
(4)
:450-451
.
(29 August 2016)
Disclosure:
1. The series “Controversies on Lung Cancer: Pros and Cons” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Suresh Senan and Helmut H. Popper served as the unpaid Guest Editors for the series.
2. The series “Evidence-Based Medicine” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
